Navigation Links
Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
Date:2/10/2009

SEATTLE, Feb. 10 /PRNewswire-FirstCall/ -- Cell Therapeutics (CTI) (NASDAQ and MTA: CTIC) today announced that they have executed a definitive collaborative agreement with IDIS to manage its investigational drug pixantrone on a named patient basis in Europe. Pixantrone will be supplied by IDIS to healthcare professionals for the treatment of individual patients with relapsing aggressive non-Hodgkin's lymphoma. This program is expected to be initiated by second quarter of 2009.

"Under the named patient program, CTI will be able to provide pixantrone to European patients in need at the prescriber's request while moving it through the approval process in the United States," noted Craig Philips, President of CTI. "With the announcement of preliminary results showing significantly higher rate of complete remission and improvement in progression-free survival for patients receiving pixantrone compared to standard chemotherapeutic agents, we expect to receive a number of requests for pixantrone to treat specific patients."

"Pixantrone is an important new treatment with impressive remission and progression-free survival data," said Dr. Raul Herbrecht of Strasbourg University Hospital in France. "This drug is also important because it meets an unmet medical need for this group of patients. I have been impressed by the good tolerance and efficacy of pixantrone since the first clinical trial we had with this drug in our department. We obtained excellent results in salvage therapy of non-Hodgkin's lymphoma in heavily pretreated patients and several years later some of our patients are still in complete response. These positive results have been confirmed in further studies," Dr Herbrecht added.

The EXTEND clinical trial was a phase III single-agent trial of pixantrone for patients with relapsed, aggressive non-Hodgkin's lymphoma who received two or more prior therapies and who were sensitive to treatment with anthra
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
2. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
3. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
4. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
5. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
6. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
7. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
8. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
11. ExonHit Therapeutics Expands Strategic Collaboration With Allergan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... Nov. 30 Henry Schein, I...lth care products and services, announced today th...resident and Chief Financial Officer, will present...y, December 1, 2009. The conference is taking pla...hein,s presentation is scheduled to begin at 9:15 ...
(Date:11/30/2009)..., Nov. 30 MedQuist Inc. ...-enabled clinical documentation services, today an...e Communications, Inc. (Nuance) under which MedQui...cognition engine and processing software for use i...t-end speech recognition application for all medic...
(Date:11/30/2009)... Nov. 30 Reportlinker.com announce...n its catalogue: ,, Decubitus Ulcer Treatment ...//www.reportlinker.com/p0164283/Decubitus-Ulcer-Tr... ,, Decubitus Ulcers are lesions resulting fro... patient,s bodyweight. Pressure ulcer treatment pr...
Breaking Medicine Technology:Henry Schein to Present at the NASDAQ OMX 23rd Investor Program 2MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Mental Health Parity Act Spurs Early Action Among Employers 50282 1Mental Health Parity Act Spurs Early Action Among Employers 50282 2Debate on admin of magnesium sulfate to pregnant women to prevent cerebral palsy in pre term infants 9043 1Debate on admin of magnesium sulfate to pregnant women to prevent cerebral palsy in pre term infants 9043 2Sevocity Launches EHR 28Electronic Health Record 29 Interface With Austin Radiological Association 50278 1Sevocity Launches EHR 28Electronic Health Record 29 Interface With Austin Radiological Association 50278 2Sevocity Launches EHR 28Electronic Health Record 29 Interface With Austin Radiological Association 50278 3
...19 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis,(ASX...any and the U.S. Food,and Drug Administration (FDA...on trial of Bronchitol for bronchiectasis via the ...cess allows for FDA evaluation of a clinical trial... efficacy claim in support of a New,Drug Applicati...
...Australian company Fermiscan,who is using a US syn...,screening test through the analysis of an individ...9% in detecting breast cancer., (Photo: http://w... recent study published in the Journal of the Amer...t breast screening using either,mammography or ult...
Other Medicine Technology:Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 2Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 3New Australian Technology: Detecting Breast Cancer With Hair 2New Australian Technology: Detecting Breast Cancer With Hair 3New Australian Technology: Detecting Breast Cancer With Hair 4
(Date:12/1/2009)...he annual meeting of the Radiological Society of N...accurate means of identifying placenta accreta, a ...on condition that is the leading cause of death fo...Due to the increase in cesarean sections and other..., coupled with women giving birth later in life, t...
(Date:12/1/2009)...netic resonance imaging (fMRI) to evaluate brain f...ead as children incur permanent brain injury. The ... of the Radiological Society of North America (RSN...he brain is spared from lead exposure," said the s...ntist at Cincinnati Children,s Hospital Medical Ce...
(Date:12/1/2009)...could lead to early degeneration in the spine, acc...eting of the Radiological Society of North America...ssociation between increased body mass index (BMI)...dy,s lead author, Judah G. Burns, M.D., fellow in ...al at Montefiore in New York City. , In this re...
(Date:12/1/2009)...ation-related injuries and deaths in the U.S. find...S. hospitals with aviation-related injuries annual...The study, conducted by researchers from the Johns...r for Injury Research and Policy and Columbia Univ...f patients were occupants of civilian, noncommerci...
(Date:11/30/2009).../ -- Being overweight as a child could lead to ear... presented today at the annual meeting of the Radi...his is the first study to show an association betw...malities in children," said the study,s lead autho...oradiology at The Children,s Hospital at Montefior...
Breaking Medicine News(10 mins):Health News:MRI helps detect life-threatening pregnancy complication 2Health News:Childhood lead exposure causes permanent brain damage 2Health News:Overweight children may develop back pain and spinal abnormalities 2Health News:More than 1,000 patients in US admitted annually for aviation-related injuries 2Health News:Overweight Children may Develop Back Pain and Spinal Abnormalities 2
...ournal Nature says that a team of Australian resea...za Hall Institute in Melbourne have successfully ...female mice that could hold the key to future brea... mammary stem cells" that escape chemotherapy and ...
...ist (CPI-M) and yoga guru Ramdev clashed violently... // reported to have raised slogans against the ...e medicines of the guru were laced with animal and...ister Anbumani Ramadoss confirmed on 4 January 200...
... health has a counter which states that heart cond...c // mutation for heart disease when they were fe...M was the mutation that the male mice carried and ...do at Boulder. Journal of clinical investigatio...
...a new study that links breakdown of myelin to the ...lifornia, Los Angeles (UCLA) researchers showed th...f myelin breakdown, may prove useful in assessing ...nt and most vulnerable process of brain developmen...
...ting trouble and is not yet launched because the n...// appointment letters to the 114consultants that... developing the rural health facilities the Rural ...puter graduate. The main work assigned to the ...
...es can help in slowing down the progress of Alzhei...y scientists from Spain and Chile. The healthy bra...ding to their study, to be published in the Americ...ized to contribute to the mental decline of Alzhei...
Other Medicine News:
...s provide protection to the exposed airway of the ...ghtweight making it ideal for active young childre...moisture recovery, it ensures patient comfort and ...rs have ISO standard tapered ends to assure a cons...
ThermoFlo Filter Special
Clear-Guard II™ with Port
...has the right product for any patient ranging from...to patients with tracheotomies. These products off... critical care applications., ,The Unti-Mist HME ...ients and staff members. This entire product line ...
Medicine Products: